Literature DB >> 11815365

Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat.

Danielle G Souza1, Vanessa A Mendonça, Maria Salete de A Castro, Steve Poole, Mauro M Teixeira.   

Abstract

Neuropeptides acting on tachykinin NK receptors play an important role in the amplification of inflammatory responses. We have assessed the effects of tachykinin NK receptor blockade on the injuries following intestinal ischaemia and reperfusion (I/R) in rats. The tachykinin NK(1) receptor antagonist SR140333 dose-dependently (0.05 to 0.5 mg kg(-1)) suppressed the local (intestine) and remote (lung) increases in vascular permeability and neutrophil recruitment following mild I/R injury. A structurally-distinct NK(1) receptor antagonist, CP99,994, but not tachykinin NK(2) or NK(3) receptor antagonists also suppressed mild I/R injury. Neonatal pretreatment with capsaicin effectively depleted sensory neurons and abrogated the injuries following mild I/R. Treatment with SR140333 (0.5 mg kg(-1)) significantly reversed severe reperfusion-induced local and remote increases in vascular permeability, neutrophil recruitment, intestinal haemorrhage and blood neutropaenia, but did not prevent the lethality associated with severe I/R. Post-ischaemic treatment with SR140333 significantly inhibited the elevations of TNF-alpha in the intestine and lung, but not serum, following severe I/R. The increase in the concentrations of IL-10 in the lung and serum were also suppressed. Post-ischaemic blockade of tachykinin NK(1) receptors markedly inhibited the local and remote injuries, but not lethality, following reperfusion of the SMA in rats. Neuropeptides, possibly substance P, released from sensory nerves appear to account for the activation of these tachykinin NK(1) receptors. Antagonists of the tachykinin NK(1) receptor may be useful adjuncts in the treatment of the injuries which occur following reperfusion of an ischaemic vascular territory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815365      PMCID: PMC1573137          DOI: 10.1038/sj.bjp.0704464

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

Review 1.  Tachykinin-eicosanoid crosstalk in airway inflammation.

Authors:  P Montuschi; P Preziosi; G Ciabattoni
Journal:  Trends Pharmacol Sci       Date:  2000-09       Impact factor: 14.819

2.  The inflammatory reaction induced by formalin in the rat paw.

Authors:  J Damas; J F Liégeois
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-03       Impact factor: 3.000

3.  Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats.

Authors:  I M Matos; D G Souza; D G Seabra; L Freire-Maia; M M Teixeira
Journal:  Eur J Pharmacol       Date:  1999-07-09       Impact factor: 4.432

4.  Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice.

Authors:  T Cao; E Pintér; S Al-Rashed; N Gerard; J R Hoult; S D Brain
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

5.  Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis.

Authors:  J N Francischi; C M Yokoro; S Poole; W L Tafuri; F Q Cunha; M M Teixeira
Journal:  Eur J Pharmacol       Date:  2000-07-07       Impact factor: 4.432

6.  Rat tumour necrosis factor-alpha: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA.

Authors:  G S Rees; C K Gee; H L Ward; C Ball; G M Tarrant; S Poole; A F Bristow
Journal:  Eur Cytokine Netw       Date:  1999-09       Impact factor: 2.737

7.  Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats.

Authors:  D G Souza; S F Coutinho; M R Silveira; D C Cara; M M Teixeira
Journal:  Eur J Pharmacol       Date:  2000-09-01       Impact factor: 4.432

8.  IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.

Authors:  N G Frangogiannis; L H Mendoza; M L Lindsey; C M Ballantyne; L H Michael; C W Smith; M L Entman
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Impaired IL-1beta-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice.

Authors:  A Ahluwalia; C De Felipe; J O'Brien; S P Hunt; M Perretti
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

10.  Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay.

Authors:  P Hagan; S Poole; A F Bristow
Journal:  J Mol Endocrinol       Date:  1993-08       Impact factor: 5.098

View more
  14 in total

1.  Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Riccardo Bertini; Angelica T Vieira; Fernando Q Cunha; Steve Poole; Marcello Allegretti; Francesco Colotta; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

2.  Anti-inflammatory effects of limb ischaemic preconditioning are mediated by sensory nerve activation in rats.

Authors:  Petra Hartmann; Renáta Varga; Zsuzsanna Zobolyák; Júlia Héger; Blanka Csosz; István Németh; Zsolt Rázga; Csaba Vízler; Dénes Garab; Péter Sántha; Gábor Jancsó; Mihály Boros; Andrea Szabó
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-23       Impact factor: 3.000

3.  APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Dirk Esser; Roberta Bradford; Angélica T Vieira; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 4.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

5.  Protease-activated receptor 2 protects against myocardial ischemia-reperfusion injury through the lipoxygenase pathway and TRPV1 channels.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

Review 6.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

8.  Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.

Authors:  Danielle G Souza; Vanessa Pinho; Jorge L Pesquero; Eliane S Lomez; Steve Poole; Luiz Juliano; Ary Correa; M Salete de A Castro; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 9.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

Review 10.  Biomarkers of cognitive dysfunction in traumatic brain injury.

Authors:  Zhao-Liang Sun; Dong-Fu Feng
Journal:  J Neural Transm (Vienna)       Date:  2013-08-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.